NCT05112874View on ClinicalTrials.gov

ImmuneSense™ COVID-19 Cross-Reactivity Study

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 15, 2021

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions
Coronavirus DiseaseSARS-CoV-2 Infection
Trial Locations (1)

98102

Adaptive Biotechnologies, Seattle

Sponsors
All Listed Sponsors
lead

Adaptive Biotechnologies

INDUSTRY